Should you invest $1,000 in Hims & Hers Health right now? Before you buy stock in Hims & Hers Health, consider this: The ...

Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS), the leading health and wellness platform, today announced Deb Autor, ...

周四，美银证券将Hims & Hers Health, Inc. (NYSE: HIMS)的评级从买入下调至表现不佳。这一决定是对亚马逊最近进入勃起功能障碍（ED）和脱发市场的直接回应，这两个领域是Hims & Hers的主要业务板块。

根据最近的SEC文件显示，Hims & Hers Health, Inc. (NYSE:HIMS)的董事Manuel Anja近期购买了该公司5,000股A类普通股。Anja于11月12日以每股$26.9399的价格购入4,000股，并于11月14日以每股$24.50的价格购入额外1,000股。这些交易总计价值$132,259。此次购买使Anja的直接所有权增加到公司5,000股。 在其他近期新闻 ...

Hims & Hers offers personalized telehealth services, with a stock price that reflects high-growth potential. See why we ...

Hims & Hers (NYSE: HIMS) is disrupting the healthcare market with its innovative patient treatment approach. Read More: Earn ...

智通财经获悉，远程医疗平台公司Hims & Hers Health(HIMS.US)首席执行官Andrew Dudum表示，该公司正准备在2025年推出诺和诺德(NVO.US)的旧版GLP-1减肥疗法liraglutide的非专利版本。liraglutide分别以Victoza和Saxenda的形式销售，用于治疗糖尿病和肥胖症。在2024年上半年，liraglutide为这家丹麦制药商带来 ...

Amazon acquired primary care provider One Medical for $3.9 billion in 2022, and fills prescriptions through Amazon One ...

Hims & Hers Health's stock dropped 25% due to Amazon’s competition. Learn why HIM stock's 38% upside and strong growth make ...

Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing ...

Shares of Hims & Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and ...

Last week, Hims & Hers Health (NYSE:HIMS) dropped another mic with its latest earnings, and the numbers are mind-blowing.